1. Whole-cell biocatalytic production of variously substituted β-aryl- and β-heteroaryl-β-amino acids.
- Author
-
Ratnayake ND, Theisen C, Walter T, and Walker KD
- Subjects
- Biocatalysis, Cell Survival, Chromatography, Gas, Cinnamates metabolism, Drug Design, Escherichia coli enzymology, Escherichia coli genetics, Intramolecular Transferases biosynthesis, Intramolecular Transferases genetics, Oxidation-Reduction, Pantoea enzymology, Phenylalanine chemistry, Stereoisomerism, Substrate Specificity, Phenylalanine biosynthesis
- Abstract
Biologically-active β-peptides and pharmaceuticals that contain key β-amino acids are emerging as target therapeutics; thus, synthetic strategies to make substituted, enantiopure β-amino acids are increasing. Here, we use whole-cell Escherichia coli (OD600 ∼ 35) engineered to express a Pantoea agglomerans phenylalanine aminomutase (PaPAM) biocatalyst. In either 5 mL, 100mL, or 1L of M9 minimal medium containing α-phenylalanine (20mM), the cells produced ∼ 1.4 mg mL(-1) of β-phenylalanine in each volume. Representative pilot-scale 5-mL cultures, fermentation reactions converted 18 variously substituted α-arylalanines to their (S)-β-aryl-β-amino acids in vivo and were not toxic to cells at mid- to late-stage growth. The β-aryl-β-amino acids made ranged from 0.043 mg (p-nitro-β-phenylalanine, 4% converted yield) to 1.2mg (m-bromo-β-phenylalanine, 96% converted yield) over 6h in 5 mL. The substituted β-amino acids made herein can be used in redox and Stille-coupling reactions to make synthetic building blocks, or as bioisosteres in drug design., (Copyright © 2015 Elsevier B.V. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF